WallStSmart

Alcon AG (ALC)vsNephros Inc (NEPH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Alcon AG generates 55257% more annual revenue ($10.40B vs $18.79M). ALC leads profitability with a 9.4% profit margin vs 6.4%. NEPH trades at a lower P/E of 28.3x. ALC earns a higher WallStSmart Score of 49/100 (D+).

ALC

Hold

49

out of 100

Grade: D+

Growth: 4.7Profit: 5.0Value: 7.3Quality: 7.3
Piotroski: 4/9

NEPH

Hold

40

out of 100

Grade: F

Growth: 6.7Profit: 5.0Value: 5.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ALCSignificantly Overvalued (-489.8%)

Margin of Safety

-489.8%

Fair Value

$13.46

Current Price

$75.26

$61.80 premium

UndervaluedFair: $13.46Overvalued
NEPHSignificantly Overvalued (-438.7%)

Margin of Safety

-438.7%

Fair Value

$0.75

Current Price

$3.05

$2.30 premium

UndervaluedFair: $0.75Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ALC2 strengths · Avg: 8.5/10
Debt/EquityHealth
0.249/10

Conservative balance sheet, low leverage

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

NEPH1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
22.2%8/10

Revenue surging 22.2% year-over-year

Areas to Watch

ALC4 concerns · Avg: 3.3/10
PEG RatioValuation
1.704/10

Expensive relative to growth rate

P/E RatioValuation
37.5x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
4.5%3/10

ROE of 4.5% — below average capital efficiency

EPS GrowthGrowth
-22.2%2/10

Earnings declined 22.2%

NEPH4 concerns · Avg: 3.3/10
P/E RatioValuation
28.3x4/10

Moderate valuation

Market CapQuality
$33.10M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
6.4%3/10

6.4% margin — thin

Operating MarginProfitability
0.4%3/10

Operating margin of 0.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : ALC

The strongest argument for ALC centers on Debt/Equity, Price/Book.

Bull Case : NEPH

The strongest argument for NEPH centers on Revenue Growth. Revenue growth of 22.2% demonstrates continued momentum.

Bear Case : ALC

The primary concerns for ALC are PEG Ratio, P/E Ratio, Return on Equity.

Bear Case : NEPH

The primary concerns for NEPH are P/E Ratio, Market Cap, Profit Margin.

Key Dynamics to Monitor

ALC profiles as a value stock while NEPH is a growth play — different risk/reward profiles.

NEPH carries more volatility with a beta of 1.48 — expect wider price swings.

NEPH is growing revenue faster at 22.2% — sustainability is the question.

ALC generates stronger free cash flow (489M), providing more financial flexibility.

Bottom Line

ALC scores higher overall (49/100 vs 40/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Alcon AG

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.

Visit Website →

Nephros Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Nephros, Inc., a commercial stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company is headquartered in South Orange, New Jersey.

Want to dig deeper into these stocks?